BRRGF
Price:
$97.094
Market Cap:
$196.15M
BerGenBio ASA is a clinical-stage biopharmaceutical firm dedicated to discovering and advancing therapies for challenging conditions. This includes cancers that are immune-evasive, drug-resistant, or metastatic, as well as various respiratory diseases. Its leading drug candidate, Bemcentinib, is an orally available, small molecule AXL inhibitor that has progressed to Phase II clinical development. This involves studies across several significant cancer indications and for COVID-19. Specifically, its Phase II trials are focused on treating non-small cell lung cancer, acute myeloid leukemia, myelodysplastic syndrome, and COVID-19. Another promising compound in its pipeline is tilvestamab, an a...[Read more]
Industry
Biotechnology
IPO Date
2018-07-23
Stock Exchange
OTC
Ticker
BRRGF
According to BerGenBio ASA’s latest financial reports and current stock price. The company's current ROE is -113.42%. This represents a change of 99.07% compared to the average of -56.98% of the last 4 quarters.
The mean historical ROE of BerGenBio ASA over the last ten years is -111.88%. The current -113.42% ROE has changed 1.38% with respect to the historical average. Over the past ten years (40 quarters), BRRGF's ROE was at its highest in in the June 2016 quarter at 0%. The ROE was at its lowest in in the December 2022 quarter at -152.70%.
Average
-111.88%
Median
-87.71%
Minimum
-341.39%
Maximum
-38.35%
Discovering the peaks and valleys of BerGenBio ASA ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 324.15%
Maximum Annual ROE = -38.35%
Minimum Annual Increase = -57.73%
Minimum Annual ROE = -341.39%
| Year | ROE | Change |
|---|---|---|
| 2024 | -113.51% | -24.00% |
| 2023 | -149.36% | -56.25% |
| 2022 | -341.39% | 324.15% |
| 2021 | -80.49% | 109.85% |
| 2020 | -38.35% | -57.73% |
| 2019 | -90.73% | 59.60% |
| 2018 | -56.85% | 9.31% |
| 2017 | -52.01% | -38.59% |
| 2016 | -84.69% | -23.96% |
| 2015 | -111.37% | 134.39% |
The current ROE of BerGenBio ASA (BRRGF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-201.42%
5-year avg
-144.62%
10-year avg
-111.88%
BerGenBio ASA’s ROE is greater than Asep Medical Holdings Inc (-58.60%), greater than Pascal Biosciences Inc. (-23.66%), less than Guardion Health Sciences, Inc. (1.48%), less than Intellipharmaceutics International Inc. (27.35%), greater than Oxford Cannabinoid Technologies Holdings Plc (-86.76%), less than Dogecoin Cash, Inc. (36.10%), greater than Invictus MD Strategies Corp. (-31.91%), greater than Field Trip Health & Wellness Ltd. (-109.89%), greater than Pixium Vision S.A. (-645.71%), less than Tryp Therapeutics Inc. (402.50%),
| Company | ROE | Market cap |
|---|---|---|
| -58.60% | $121.25K | |
| -23.66% | $4.20M | |
| 1.48% | $4.17M | |
| 27.35% | $4.96M | |
| -86.76% | $3.05M | |
| 36.10% | $1.38M | |
| -31.91% | $4.45M | |
| -109.89% | $3.71M | |
| -645.71% | $4.62M | |
| 402.50% | $5.42M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BerGenBio ASA using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BerGenBio ASA or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is BerGenBio ASA's ROE?
How is the ROE calculated for BerGenBio ASA (BRRGF)?
What is the highest ROE for BerGenBio ASA (BRRGF)?
What is the 3-year average ROE for BerGenBio ASA (BRRGF)?
What is the 5-year average ROE for BerGenBio ASA (BRRGF)?
How does the current ROE for BerGenBio ASA (BRRGF) compare to its historical average?